IQVIA Holdings Inc.
NYSE:IQVMedical - Diagnostics & Research
-$3.13 today
- Market cap
- $42.49B
- Beta
- 1.22
- P/E (TTM)
- 20.4
- EPS (TTM)
- $8.22
Volume 1.40M
Average 1.62M
IQV Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
IQVIA Holdings Inc.NYSE: IQV
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization grows in line with its trailing trend
Q2 FY2026 depreciation & amortization of $292M rose 5.8% year over year, in line with the +5.4% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 1.4% from the prior quarter. Over 3 fiscal years it compounded at -17.3% a year.
Context
- Depreciation & amortization amounted to 3.9% of revenue in FY2025, down 3.3 pp from a year earlier.
- Depreciation & amortization increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +5.8% holds above the trailing-twelve-month pace of +5.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 640M USD
- Year-over-year change
- -42.5%
- 4-year CAGR
- -15.6%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 640M | -42.5% |
| FY2024 | 2024-12-31 | 1.11B | -1.0% |
| FY2023 | 2023-12-31 | 1.13B | -0.4% |
| FY2022 | 2022-12-31 | 1.13B | -10.6% |
| FY2021 | 2021-12-31 | 1.26B | — |
Depreciation & Amortization vs competitors
How IQV compares with its peers on the latest reported figures
- IQV's LTM Jun 2026 depreciation & amortization of $1.18B is the highest of the 9 companies compared; the peer median is $67.67M.
- Its year-over-year change of +5.4% is the 5th highest of 9, against a peer median of +1.2%.
- Depreciation & amortization amounts to 7.0% of revenue for IQV, versus a peer median of 6.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.18B | +5.4% | -17.3% | 7.0% | |
| LTM Jun 2026 | $575.54M | +50.1% | -12.4% | 7.0% | |
| LTM Jun 2026 | $297.88M | -30.8% | +9.9% | 7.4% | |
| LTM Sep 2026 | $79.07M | -6.8% | +49.8% | 5.2% | |
FTREFortrea Holdings Inc. | LTM Jun 2026 | $78.3M | -3.5% | -5.9% | 2.9% |
| LTM Mar 2026 | $57.03M | +5.9% | +2.5% | 13.6% | |
| LTM Mar 2026 | $50.3M | +16.4% | -0.7% | 16.6% | |
| LTM Jul 2026 | $46.23M | +16.1% | +20.1% | 1.3% | |
| LTM Sep 2026 | $27.48M | -3.6% | +8.0% | 1.0% | |
| Peer median (excluding IQV) | $67.67M | +1.2% | +5.3% | 6.1% | |
Competitors are the stored peer set for IQV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 13.87B | 14.41B | 14.98B | 15.41B | 16.31B |
| Cost of Revenue | 9.23B | 9.38B | 9.75B | 10.03B | 10.88B |
| Gross Profit | 4.64B | 5.03B | 5.24B | 5.38B | 5.43B |
| Gross Margin | 33.5% | 34.9% | 35.0% | 34.9% | 33.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.96B | 2.07B | 2.05B | 1.99B | 1.99B |
| Operating Expenses | 3.25B | 3.23B | 3.26B | 3.17B | 3.25B |
| Depreciation & Amortization | 1.26B | 1.13B | 1.13B | 1.11B | 640M |
| EBITDA | 2.77B | 2.91B | 3.26B | 3.45B | 2.94B |
| EBITDA Margin | 19.9% | 20.2% | 21.7% | 22.4% | 18.0% |
| Operating Income | 1.39B | 1.8B | 1.98B | 2.2B | 2.18B |
| Operating Margin | 10.0% | 12.5% | 13.2% | 14.3% | 13.4% |
| Interest Income | 6M | 13M | 36M | 47M | 45M |
| Interest Expense | 375M | 416M | 672M | 670M | 729M |
| Other Income / Expenses | (259M) | (448M) | (518M) | (533M) | (569M) |
| Income Before Tax | 1.13B | 1.35B | 1.46B | 1.67B | 1.61B |
| Pre-Tax Margin | 8.2% | 9.4% | 9.7% | 10.8% | 9.9% |
| Income Tax Expense | 163M | 260M | 101M | 296M | 252M |
| Net Income | 966M | 1.09B | 1.36B | 1.37B | 1.36B |
| Net Margin | 7.0% | 7.6% | 9.1% | 8.9% | 8.3% |
| EPS (Basic) | 5.05 | 5.82 | 7.39 | 7.57 | 7.91 |
| EPS (Diluted) | 4.95 | 5.72 | 7.29 | 7.49 | 7.84 |
| Weighted Avg Shares | 191.4M | 187.6M | 183.8M | 181.3M | 171.9M |
| Weighted Avg Shares (Diluted) | 195M | 190.6M | 186.3M | 183.4M | 173.5M |
IQVIA Holdings Inc.
NYSE:IQV
Intrinsic Alpha fair value
Locked
Current Price
$257.84
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.